fluoro prostaglandinas utilizadas como hipotensores oculares. . Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma. Generate link with comments. Analogos de tetrahidrofurano sustituido de prostaglandinas como hipotensores oculares. Abstract. translated from. Classifications. En los casos más leves, es muy probable que la enfermedad se mantenga bajo control con la utilización de colirios hipotensores oculares. Estos colirios se han .

Author: Tauzshura Yolkree
Country: Mali
Language: English (Spanish)
Genre: Literature
Published (Last): 5 October 2007
Pages: 431
PDF File Size: 4.56 Mb
ePub File Size: 16.69 Mb
ISBN: 155-2-89650-460-8
Downloads: 5421
Price: Free* [*Free Regsitration Required]
Uploader: Nikoll

Glaukos Corporation Full Title: Ocular surface damage by ophthalmic compounds. J Ocul Pharmacol Ther. Key questions in dry eye history. Reliability and validity of the ocular surface disease index. The epidemiology of dry eye disease: Longer duration since diagnosis is significantly correlated with worsening of OSD symptoms.

Clear advanced search filters. Cosmetic and pharmaceutical compositions and methods using 2-decarboxyphosphinico derivatives. Male, Female Trial protocol: Control and pilocarpine had a percentual IOP increase after 2 hours of 8. Open angle glaucoma or hipitensores hypertension.

Glaucoma | Innova ocular

Conjunctival impression cytology in patients with glaucoma using long-term topical medication. Open-angle glaucoma; Ofulares hypertension; Keratoconjunctivitis sicca; Blepharitis; Benzalkonium compounds. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension.


All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension. De maneira semelhante, Henry et al.

How to cite this article.

Clinical trials for latanoprost/timolol

A week randomised, evaluator-masked, parallel-group, multinational, multi-centre study comparing the efficacy and safety of the fixed combination of latanoprost and timolol XalacomTM with the SI Ongoing Trial results: Um estudo realizado por Uusilato et al. Interpretation of the correlation coefficient a basic review. In this cross-sectional study, 40 patients were consecutively oculages from the glaucoma clinic of a public hospital located in Rio de Janeiro, Brazil.

Allergan Limited Full Title: Displaying page 1 of 1. Trials with results Trials without results Clear advanced search filters. Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma. Prospective, multicentric, hipotensorres clinical study to compare the efficacy and safety of Ganfort and Duotrav in primary open angle and pseudoexfoliative glaucoma patients previously treated wi Derivados amino ramificados del tiazol, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.

The following data were considered: IT Completed Trial results: Diagnostic tests in the Sicca syndrome. Dispositivo para la amplificacion electroacustica de un instrumento de cuerda con un boton de sujecion de las cuerdas.


Patients with primary open-angle glaucoma or ocular hypertension on topical intraocular pressure-lowering therapy have high prevalence of OSD. View results EudraCT Number: Signs and symptoms of ocular surface disease in patients on topical intraocular pressure-lowering therapy.

Trials with results Trials without results. The hipotensires IOP did not differ statistically among groups. Department of Clinical Pharmacology Full Title: A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma. Ocular hypertension; Lens capsule, crystalline; Lasers; Antihypertensive agents. GR Ongoing Trial results: EU Clinical Trials Register. Country of ref document: Apraclonidine caused higher hypotensive effect after capsulotomy with YAG laser when compared with brimonidine, dorzolamide, latanoprost, pilocarpine, timolol and control group.

Ocular hypertension would be considered if the IOP had suffered an increase of 4 mmHg above the initial.

Cyclopentane heptan hipogensores oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents. Mean total energy used was 2. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds. IOP measurements Goldmann applanation tonometry were taken under masked conditions 1 hour before procedure and after 1 and 2 hours.